NVRO Projected Dividend Yield
Nevro Corp ( NYSE : NVRO )Nevro is a medical device company focused on delivering solutions for patient with pain treatment. Co. has developed and commercialized the Senza® spinal cord stimulation (SCS) system, a neuromodulation platform for the treatment of chronic pain, with the Senza® Omnia™ platform being an addition to the Senza family of products. Co.'s proprietary, paresthesia-free 10 kHz Therapy, delivered by its Senza system is designed to treat back pain and leg pain. In addition, Co. received approval of unilateral or bilateral pain, associated with painful diabetic neuropathy and expanded labeling in non-surgical refractory back pain. 20 YEAR PERFORMANCE RESULTS |
NVRO Dividend History Detail NVRO Dividend News NVRO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |